Search for: "The Regulatory Review"
Results 2221 - 2240
of 28,465
Sorted by Relevance
|
Sort by Date
10 Jan 2023, 9:03 pm
If it does, it may have the potential to provide the framework for a legislative response to the new doctrine that seeks to reconcile democratic accountability with regulatory flexibility.The post Rapid Responses to Major Questions first appeared on The Regulatory Review. [read post]
7 Aug 2023, 9:26 am
If you enjoy listening to LawNext, please leave us a review wherever you listen to podcasts. [read post]
15 Nov 2022, 9:05 pm
first appeared on The Regulatory Review. [read post]
25 Apr 2024, 6:52 am
Go big or go home, they say. [read post]
4 Jun 2020, 1:06 pm
However, what are the privacy and regulatory concerns related to the use of these apps? [read post]
10 Nov 2023, 6:00 am
The review is co-published with Tech Policy Press here.) [read post]
25 Apr 2021, 9:08 pm
Quantitative benefit-cost analysis (BCA) is a central component of the current regulatory review process in the United States. [read post]
3 Mar 2014, 8:13 am
Further, in choosing among alternative regulatory approaches, agencies should select those approaches that maximize net benefits, including potential economic, environmental, public health and safety, unless a statute requires another regulatory approach.Finally, H.R. 899 would extend judicial review to the selection of the least costly or least burdensome regulatory alternative and to the principles of Executive Order 12866. [read post]
26 Aug 2021, 4:00 am
Several times each month, we are pleased to republish a recent book review from the Canadian Law Library Review (CLLR). [read post]
21 Dec 2023, 9:05 pm
We just have to decide to use them.The post The Promise of Next Generation Compliance first appeared on The Regulatory Review. [read post]
22 Mar 2020, 9:05 pm
Just after the order was issued, I wrote an article for The Regulatory Review describing how this order would impose an arbitrary regulatory budget—forcing agencies to ignore the benefits of new regulations and, instead, to focus only on the costs to corporations and other regulated entities. [read post]
27 Jul 2015, 9:45 pm
Movie reviewers summarize their assessments using symbols that range from stars to thumbs up to the ripeness of tomatoes. [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
31 Dec 1969, 4:00 pm
NRDC, the Sustainable FERC Project (in which NRDC is a member), and 60 other public interest organizations sent a clear message this week to the Federal Energy Regulatory Commission (FERC): it’s time for FERC to reform the way it evaluates applications fo [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
18 Dec 2024, 10:00 pm
China’s main healthcare regulatory bodies, including the National Medical Products Administration, released draft administrative measures for pharmaceutical representatives intended to strengthen anti-corruption efforts and clarify obligations and compliance expectations in China’s healthcare industry. [read post]
20 Sep 2022, 9:04 pm
The review officially launched on Sept. 8, and is scheduled to culminate 60-business-days later on Dec. 6, in a report to Califf. [read post]
